How do non-keratocystic lesions respond to decompression?

Area of Science:

• Oral and Maxillofacial Surgery
• Craniofacial Biology
• Oncology

Background:

• Non-keratocystic lesions pose treatment challenges.
• Decompression is a minimally invasive technique for managing cystic lesions.
• Understanding lesion response to decompression is crucial for treatment planning.

Purpose of the Study:

• To assess the efficacy of decompression in reducing the volume of non-keratocystic jaw lesions.
• To quantify the volumetric changes in various non-keratocystic lesions following decompression.

Main Methods:

• Retrospective cohort study of 56 patients (2017-2022).
• Inclusion criteria: decompression tube placement, histopathologically confirmed non-keratocystic lesion, pre/post-CBCT for volumetric analysis.
• Statistical analysis using ANOVA and t-tests (P < .05).

Main Results:

• Decompression achieved significant volume reduction in dentigerous cysts (64.4%), periapical cysts (46.3%), and inflammatory cysts (45.2%).
• Lesion diagnosis did not significantly predict the rate or magnitude of volume reduction.
• Ameloblastomas showed variable responses, with some increasing in size during decompression.

Conclusions:

• Decompression is a viable treatment for reducing the size of dentigerous, periapical, and inflammatory cysts.
• Decompression is not recommended for ameloblastomas due to unpredictable behavior and potential for delayed definitive treatment.
• This study highlights the differential response of non-keratocystic lesions to decompression therapy.